Ridha Charfeddine and others acquired 6.85% stake in Unité de Fabrication des Médicaments (BVMT:UMED) from SQM Frontier Africa Master Fund, Ltd., managed by SQM Frontier Management, LP on August 23, 2020. Post acquisition Ridha Charfeddine now holds 29.23% directly and 40.77% jointly, or 70% of Unimed's capital. Ridha Charfeddine will acquire 2.15 million shares, representing 6.74% stake. Ridha Charfeddine and others completed the acquisition of 6.85% stake in Unité de Fabrication des Médicaments (BVMT:UMED) from SQM Frontier Africa Master Fund, Ltd., managed by SQM Frontier Management, LP on August 23, 2020.